Bringing clinical trial enrollment to the point of diagnosis
Recruiting patients continues to be one of the most enduring challenges facing clinical trials, further intensified by the rising number of studies and the complexity of trial protocols. Finding eligible participants is especially challenging for conditions like inflammatory bowel disease (IBD), due to the high competition among available treatments and a vigorous pipeline of new therapies.
This white paper explores:
- Harnessing digital data to transform patient recruitment
- Advancing recruitment with artificial intelligence
- Revolutionizing recruitment across therapeutic areas
The PPD™ clinical research business of Thermo Fisher Scientific has expanded its patient locating capabilities to power recruitment strategies. Through a partnership with Virgo, which leverages AI-driven technology to analyze real-time endoscopy data, we are advancing the recruitment process and enhancing clinical trial efficiency.
